| Endpoints | Complement-Binding DSA (n=23) | No DSA (n=360) | P-Value |
|---|---|---|---|
| 5 Year Survival | 73.9% | 86.7% | 0.145 |
| 5 Year Freedom from CAV | 95.7% | 86.9% | 0.214 |
| 5 Year Freedom from NF-MACE | 47.8% | 79.2% | <0.001 |
| Complement-Binding DSA (n=23) | |||
|---|---|---|---|
| Endpoints | Class I Ab (n=6) | Class II Ab (n=17) | P-Value |
| 5 Year Survival | 100.0% | 64.7% | 0.155 |
| 5 Year Freedom from CAV | 100.0% | 94.1% | 0.552 |
| 5 Year Freedom from NF-MACE | 50.0% | 47.1% | 0.473 |